Suanova, InfiX.ai Partner for Medical AI
Analysis based on 6 articles · First reported Jun 10, 2026 · Last updated Jun 10, 2026
This strategic cooperation between Suanova Technology Limited>>> and InfiX.ai>>> is expected to positively impact the technology and healthcare sectors by accelerating the adoption of medical AI. For Maqam International Holding>>>, this partnership signifies a strategic expansion into the AI compute sector, potentially boosting its market position and stock performance.
Suanova Technology Limited>>>, a wholly-owned subsidiary of Maqam International Holding>>>, has entered into a comprehensive strategic cooperation agreement with InfiX.ai>>>, a global leader in enterprise-grade generative AI infrastructure solutions. The collaboration aims to jointly advance the deployment of training and inference integrated AI platforms with continuous self-learning capabilities, initially focusing on healthcare applications. Suanova Technology Limited>>> will leverage its Shanghai Cube, a domestically developed high-density computing infrastructure, to provide core computing power and foundational support. The partnership will integrate InfiX.ai>>>'s training, inference, and multimodal AI capabilities with Shanghai Cube to create a unified hardware-software infrastructure tailored for medical AI. This initiative is expected to accelerate the adoption of medical AI in clinical settings and advance the domestic computing ecosystem in China>>> and China — Hong Kong>>>. Key figures involved include Yang Xiaocui>>>, Founder and Chief Scientist of InfiX.ai>>>, and Daliang Chen>>>, CEO of Suanova Technology Limited>>>.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard